Feinstein Institute

Rockefeller researcher nabs Feinstein’s molecular prize

Advanced molecular-genetics studies have earned a Rockefeller University researcher accolades from the Feinstein Institute for Medical Research, and a fat check. While Feinstein Institute scientists are often the ones collecting the research prizes, this time the institute is dishing it out, naming Jeffrey Ravetch – head of the Leonard Wagner Laboratory of Molecular Genetics and Immunology at The Rockefeller University in New York City – the recipient of the fifth-annual Ross Prize in Molecular Medicine….


Energy, life sciences pace 2017 Innovation Boot Camp

By GREGORY ZELLER // Several innovators sitting on potentially game-changing technologies have been selected for one of Long Island’s most effective commercialization crash courses. Stony Brook University has announced the eight teams participating in the 10th annual Innovation Boot Camp, a three-day exercise that surrounds researchers, engineers and other rookie entrepreneurs with customized teams of commercialization experts to help them explore the rigors of business development. This year’s boot campers represent a diverse selection of…


GE brings good things to bioelectronics research

By GREGORY ZELLER // General Electric is giving the Feinstein Institute for Medical Research a bioelectronic jolt. The Feinstein Institute, R&D mecca of the Northwell Health system, announced a new “strategic alliance” Tuesday with GE Ventures, the multinational conglomerate’s New Jersey-based business-licensing and equity arm. While no financial terms were disclosed, Northwell Health did note an “investment” that will help the Feinstein Institute’s evolving Center for Bioelectronic Medicine “continue its work in discovering, developing and…


Feinsteins donate $25M (again) to Northwell research

By GREGORY ZELLER // The Feinsteins have gone Bed, Bath & Beyond the call of duty, once again. Susan Feinstein and her husband, Leonard, co-founder and co-chairman of the New Jersey-based national housewares chain, announced Friday a fresh $25 million donation to Northwell Health’s Feinstein Institute for Medical Research – the health system’s busy Manhasset R&D hub, renamed in 2005 following the Feinsteins’ first $25 million gift. The new endowment will “further expand its research…


Study: Texting can deter alcohol abuse

By GREGORY ZELLER // A first-of-its-kind study conducted by the Feinstein Institute for Medical Research has found that text messaging can be an effective alcohol-abuse deterrent. Feinstein Institute researchers led by Frederick Muench, director of Northwell Health’s Digital Health Interventions in Psychiatry unit, conducted a 12-week controlled pilot study of 152 participants interested in curtailing their drinking problems. The results, in a nutshell: Drinkers who received “adaptive-tailored texts” were able to reduce their drinking at…


Feinstein’s unexpected postpartum blessing

By GREGORY ZELLER // The Feinstein Institute for Medical Research has contributed to a potential breakthrough involving postpartum depression, a serious condition affecting hundreds of thousands of new mothers. Kristina Deligiannidis, an associate professor at the Feinstein Institute and the Hofstra Northwell School of Medicine, joined colleagues at the University of Massachusetts Medical School and Tufts University’s Cummings School of Veterinary Medicine on a study that indicates synthetic oxytocin – a common medication administered during…


Still cutting its teeth, Traverse set for stellar 2017

By GREGORY ZELLER // First, healthy teeth for dogs … then a cancer cure for the world? Financially and otherwise, Traverse Biosciences enjoyed a strong 2016 – but it may ultimately pale compared to what’s shaping up as a potentially enormous 2017 for the Stony Brook biotech and its flagship pharmaceutical. Fueled primarily by a $1.32 million Phase II Small Business Technology Transfer award granted by the National Institutes of Health in August to the…


LI Bioscience Hub backs 10 in new funding round

By GREGORY ZELLER // A fresh batch of commercially promising biomedical innovations has been funded by the Long Island Bioscience Hub. The LIBH’s third round of grant awards – bestowed upon 10 distinct applicants hailing from Stony Brook University, Cold Spring Harbor Laboratory and the Feinstein Institute for Medical Research, three of the hub’s four partner institutions – totals $550,000. Stony Brook-based research earned seven of the awards, including the only $100,000 “proof of concept”…


New veeps target Feinstein Institute growth

Hungry for growth, the Feinstein Institute for Medical Research has beefed up its administrative team. Following a year of groundbreaking research and ambitious business ventures, the bioelectronic medicine-friendly institute has named John David Chelico its new vice president of research information technology and Ivar Strand its new vice president of research finance, a position that monitors critical bottom-line practices around Feinstein’s breakthrough R&D. Both Chelico – who will be tasked with developing a “data core”…


Nerves of steel: Sanguistat stimulator steps up

By GREGORY ZELLER // The world’s leading cause of maternal deaths is the target of new clinical trials for a trailblazing bioelectronic medical device. The Neural Tourniquet, an electronic nerve-stimulation technology licensed to Sanguistat Inc. by the Feinstein Institute for Medical Research, is seeing action against postpartum hemorrhage in new clinical trials underway at Feinstein, the research arm of the Northwell Health system. Sanguistat, a 2016 clinical-stage medical device spinoff founded by Feinstein Vice President…


At Northwell Health, putting their backs into it

By GREGORY ZELLER // Potential triggers for crippling backaches and revolutionary cancer treatments marked a big week for the human spine at Northwell Health. First, on Nov. 14, the health system announced that North Shore University Hospital had become the first center in the eastern U.S., and second nationally, to perform combined kyphoplasty intraoperative radiation therapy – a cutting-edge treatment for spinal metastasis, a common development for all patients with systemic cancers. The Feinstein Institute…


Centricity event highlights Feinstein heart, tech

By GREGORY ZELLER // The Feinstein Institute flexed its investigative muscle Nov. 10, highlighting the awesome breadth of its clinical research programs in a day-long symposium at its Manhasset headquarters. Covering everything from cutting-edge neurosurgical techniques to shifting paradigms in thromboembolic-disease research to new mental illness-related technologies, Centricity Series Symposia: Clinical Research 2016 was designed specifically to show how the Feinstein Institute for Medical Research, the R&D arm of the Northwell Health system, is improving…


Debrief: Scientifically, Kevin Tracey is all business

Fresh off keynoting an international symposium at the New York Academy of Sciences, bioelectronic medicine pioneer Kevin Tracey is (as usual) busily overseeing operations at the groundbreaking Feinstein Institute for Medical Research. That includes bioelectronics R&D, though Tracey is adamant that science – not sales – is Feinstein’s focus (example: he claims no involvement with a spinoff company based on his nerve-stimulating expertise). For the Feinstein president, collaboration and discovery set the tone, and the…


NIH pumps $3M into Feinstein autism study

The National Institutes of Health will fund a two-year Feinstein Institute for Medical Research study exploring risk factors behind autism spectrum disorders in newborns. A $3 million NIH grant has been awarded to MDs Betty Diamond and Peter Gregersen, researchers in the Northwell Health System’s Manhasset-based R&D division, specifically to explore the relationship between a mother’s autoimmunity during pregnancy and the risk of ASD in her child. The researchers are following up previous studies in…


Feinstein eyes bioelectronic BP breakthrough

A new study by the head of the Feinstein Institute for Medical Research may open the door to bioelectronic treatments for hypertension and high blood pressure. In a study published this month by the prestigious peer-reviewed scientific journal Nature Biotechnology, researchers from the Feinstein Institute – the R&D arm of the Northwell Health system – and the Karolinska Institutet, Sweden’s top medical university, discuss findings regarding T-cells and their ability to produce neurotransmitters that can…